Fluicell CEO Newsletter 06, 2021

In the sixth issue of the Fluicell CEO Newsletter for 2021, Victoire Viannay covers Fluicell’s advances in regenerative…

Read more
29 Sep 2021

Fluicell makes progress in early development of advanced therapy medicinal products for diabetes based on Biopixlar

Today, Fluicell announces that the company has made important progress in the early development work regarding a medicinal…

Read more
16 Sep 2021

Fluicell at Erik Penser Bank Life Science Day

Fluicell’s CEO Victoire Viannay will present the company, what our current focus is and our plans for the…

Read more
14 Sep 2021

Pressure differences influence cell division

Cytokinesis, or cell division, is one of the most fundamental process in biology. The division of one cell…

Read more
25 Aug 2021

Delårsrapport Q2

Under första hälften av 2021 har Fluicell gjort viktiga framsteg på flera viktiga områden, inte minst genom lanseringen…

Read more
20 Aug 2021

Meet Fluicell in July

July comes with several opportunities to meet with Fluicell and discuss everything from single-cell biology and bioprinting to…

Read more
28 Jun 2021

Fluicell welcomes Niek Welkenhuysen

Fluicell welcomes Niek Welkenhuysen who started with us in May as a development engineer. Although Niek recently joined…

Read more
14 Jun 2021

BioPen Nanoparticle Delivery

We have just released a new application example for BioPen®, covering nanoparticle delivery for single-cell biology. Using Fluicell’s…

Read more
10 Jun 2021

Fluicell CEO Newsletter 04, 2021

The announcement of the BioRej™ Advance program for regenerative medicine partnerships in the beginning of May was the…

Read more
01 Jun 2021